RenewRx Achieves SOC 2 Type 1 Security Compliance, Reinforcing Commitment to Data Protection Denver, CO — November 27, 2025 — RenewRx, a digital women’s health platform, today announced that it has successfully achieved SOC 2 Type 1 Security compliance. This certification marks a major milestone in RenewRx’s ongoing commitment to safeguarding sensitive health information...
DENVER, CO — November 21, 2025 — RenewRx, a women’s digital health platform redefining care starting in pregnancy, will be featured in the Colorado BioScience Association’s new 2025–2026 BioScience Colorado Magazine — a publication celebrating the scientists, founders, and companies driving discovery across the state’s thriving life sciences ecosystem. This year’s theme, “Driven. By Science....
RenewRx Wins International FemTech Product of the Year at MedTech Malta 2025 Denver, CO — November 18, 2025 — RenewRx, a leader in digital maternal-health innovation, has been named FemTech Product of the Year at MedTech Malta 2025, a global event celebrating the world’s top healthcare innovators and investors. The award honors the most impactful...
RenewRx Selected as Semifinalist in 2025 Prime Health Innovation Challenge We’re honored to share that RenewRx has been named a semifinalist in the 2025 Prime Health Innovation Challenge (https://www.primehealthco.com/press-releases/2025-prime-health-innovation-challenge-semifinalists-announced)! Hosted by Prime Health Colorado, this prestigious program highlights the nation’s top digital health innovators dedicated to improving care delivery, health equity, and...
RenewRx Selected for 2025 MedTech Innovator Cohort, Pioneering Scalable Solutions for Maternal Diabetes Care Denver, CO – [June 7th, 2025] — RenewRx, a digital health platform transforming care for pregnant patients with diabetes, has been selected as one of just 65 startups worldwide to join the prestigious 2025 MedTech Innovator Cohort—chosen from a competitive...
RenewRx Expands Integration with Dexcom, a Leader in Continuous Glucose Monitoring (CGM) Denver, CO – [October 1, 2025] — RenewRx, a digital health platform transforming women’s healthcare, starting in pregnancy, today announced a new integration with Dexcom, a global leader in continuous glucose monitoring (CGM). With this expansion, expectant mothers using Dexcom CGM...
RenewRx Featured on Diabetech Podcast: Reimagining Diabetes Care During Pregnancy Denver, CO – [November 4, 2025]— RenewRx, a women’s health platform transforming diabetes care starting in pregnancy, was recently featured on the Diabetech Podcast in an episode titled “How RenewRx Aims to Transform Diabetes Care During Pregnancy.” Pregnancy with diabetes can feel overwhelming—and our healthcare...
RenewRx Named Finalist in $10K #MTIBestVideo Contest, Highlighting Innovation in Prenatal Care Denver, CO – [September 2nd, 2025] — RenewRx, a virtual health platform transforming prenatal care, has been named a finalist in the $10,000 #MTIBestVideo Contest, recognizing innovative companies advancing digital health and patient-centered care. The company’s OneTh1ng™ coaching program empowers women...
RenewRx Chosen as Finalist for MedTech Malta 2025 Showcase Denver, CO — [September 19, 2025] — RenewRx, an emerging leader in maternal health innovation, has been selected as one of only 10 MedTech Innovator companies invited to present at MedTech Malta 2025, taking place November 12–14 at the Mediterranean Conference Centre in Valletta, Malta. RenewRx is one...
RenewRx Named One of Six Finalists in the 2025 Prime Health Innovation Challenge Denver, CO – September 11, 2025 — RenewRx Health, PBC has been selected as a Finalist in the prestigious 2025 Prime Health Innovation Challenge, a nationally recognized competition advancing healthcare innovation, held annually in Colorado. Finalists are the top six...
